CovaxinCovaxin, India's first home-made shots against COVID-19, has shown high levels of antibody response in a mid-stage trial.
The company said it had shown 81% efficacy in preventing symptomatic COVID-19, based on interim analysis of late stage trials.The vaccine has been developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV), Pune.